Amneal Pharmaceuticals Inc Class A (AMRX)
Amneal Pharmaceuticals stock today
Amneal Pharmaceuticals closed at $21.51 on October 30, 2026, up 0.75% on the day. Over the past year it returned +115.1% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $6.86 billion.
| Period | AMRX | S&P 500 (SPY) |
|---|---|---|
| 1 month | +6.8% | -0.9% |
| 3 months | +16.3% | +2.1% |
| Year to date | +70.7% | +11.7% |
| 1 year | +115.1% | +12.4% |
| 3 years | +454.4% | +88.5% |
| 5 years | +291.8% | +76.0% |
Key statistics
- Market value
- $6.86B
- P/E (trailing)
- 44.8
- Forward P/E
- 19.2
- Price / sales
- 2.2
- 52-week range
- $10.00 to $21.51
- Next report
- Nov 3, 2026
About Amneal Pharmaceuticals
Amneal Pharmaceuticals manufactures and distributes generic and specialty pharmaceutical products.
Sector: Health Care
More on Amneal Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue +8% in the year to Dec 2025
- Valuation: P/E history and peersP/E 44.8, median 57.3 at its last 3 year ends
- Returns: what $1,000 became$1,000 ten years ago is $1,039 today
No forecast, no recommendation. This page describes Amneal Pharmaceuticals Inc Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.